Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$34,619 Mln
P/E Ratio
26.44
P/B Ratio
6.24
Industry P/E
87.38
Debt to Equity
0.12
ROE
0.26 %
ROCE
17.84 %
Div. Yield
0.9 %
Book Value
--
EPS
8.9
CFO
$5,283.93 Mln
EBITDA
$8,240.34 Mln
Net Profit
$4,886.20 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
ResMed (RMD)
| 2.38 | 5.17 | -8.07 | 7.37 | 2.93 | 7.54 | 13.75 |
|
BSE Sensex*
| 2.75 | 3.86 | 5.93 | 9.05 | 11.81 | 20.15 | 11.37 |
|
S&P Midcap 400
| -8.80 | -4.26 | -12.25 | -1.81 | 4.06 | 11.99 | 6.45 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
ResMed (RMD)
| 32.64 | -17.35 | -20.10 | 22.54 | 37.16 | 36.09 | 34.24 |
|
S&P Midcap 400
| 12.12 | 14.45 | -14.48 | 23.21 | 11.81 | 24.05 | -12.43 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 102.18 | 150,717.24 | 74.38 | 19.68 | |
| 514.01 | 184,438.33 | 75.23 | 15.04 | |
| 421.34 | 161,061.03 | 24.88 | 13.25 | |
| 216.12 | 15,414.43 | 33.68 | 17.19 |
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers... various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. Address: 9001 Spectrum Center Boulevard, San Diego, CA, United States, 92123 Read more
CEO & Chairman
Mr. Michael J. Farrell BE, MBA, SM
CEO & Chairman
Mr. Michael J. Farrell BE, MBA, SM
Headquarters
San Diego, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of ResMed Inc (RMD) stood at $ 8,507 Mln as on 31-Mar-25
The share price of ResMed Inc (RMD) is $234.14 (NYSE) as of 28-Apr-2025 16:04 EDT. ResMed Inc (RMD) has given a return of 2.93% in the last 3 years.
ResMed Inc (RMD) has a market capitalisation of $ 34,619 Mln as on 28-Apr-2025. As per Value Research classification, it is a Mid Cap company.
The P/B ratio of ResMed Inc (RMD) is 6.24 times as on 28-Apr-2025, a 74% premium to its peers’ median range of 3.59 times.
The P/E ratio of ResMed Inc (RMD) is 26.44 times as on 28-Apr-2025, a 70% discount to its peers’ median range of 87.38 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the ResMed Inc (RMD) and enter the required number of quantities and click on buy to purchase the shares of ResMed Inc (RMD).
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. Address: 9001 Spectrum Center Boulevard, San Diego, CA, United States, 92123
The CEO & director of Mr. Michael J. Farrell BE, MBA, SM. is ResMed Inc (RMD), and CFO & Sr. VP is Mr. Michael J. Farrell BE, MBA, SM.
There is no promoter pledging in ResMed Inc (RMD).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,577
|
|
|
17,481
|
|
|
16,411
|
|
|
14,631
|
| ResMed Inc. (RMD) | Ratios |
|---|---|
|
Return on equity(%)
|
24.45
|
|
Operating margin(%)
|
31.86
|
|
Net Margin(%)
|
26.15
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of ResMed Inc (RMD) was $0 Mln.
$-1.74
(
